Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

New D.C. Office Strengthens ACR Advocacy Efforts

  |  

As hearings and other policy meetings come up, these D.C. staffers will be there on behalf of the ACR/ARP membership to engage in ongoing communication with Congress and regulatory agencies on the critical issues impacting rheumatology.

Their proactive advocacy work will include hosting rheumatology advocates who visit the Hill to speak with senators and representatives in Congress. They also will advance the reach of RheumPAC, the rheumatology political action committee that facilitates educating, electing and supporting federal lawmakers who address the issues that impact rheumatology care providers and their patients.

ADVERTISEMENT
SCROLL TO CONTINUE

Looking to engage in the ACR’s advocacy work? Get involved by exploring the Legislative Action Center to get legislative alerts and learn more about legislation impacting your practice.

Carina Stanton is a freelance science journalist based in Denver.

ADVERTISEMENT
SCROLL TO CONTINUE

Related Articles

    In Advocacy, Slow and Steady Wins the Race

    Earlier in the year, it seemed that healthcare reform was stopped in its tracks because of the Massachusetts Senate special election—which placed Republican Scott Brown in the seat held by the “Liberal Lion,” Edward M. Kennedy. The Senate Democrats lost their supermajority and the momentum to pass President Obama’s healthcare reform legislation subsided. But through strong lobbying by the president, Speaker Nancy Pelosi (D-Calif.), and Senate Majority Leader Harry Reid (D-Nev.), Congress passed the Patient Protection and Affordable Care Act (H.R. 3590)—comprehensive healthcare reform—on March 21, and the president signed the bill into law on March 23.

    The Power of Advocacy

    In 1916, a handful of conservation advocates successfully lobbied Congress to create the National Park Service, which now protects more than 85 million acres of U.S. land. Dedicated rheumatology advocacy has lasting effects, too, as evidenced by several policy wins in 2021 and efforts underway for 2022.